Point-of-care urinary pneumococcal antigen test in the emergency department for community acquired pneumonia

Emergency Medicine Journal

Volumn 25, Issue 3, 2008, Pages 144-148

  Weatherall, C ^a   Paoloni, R ^a   Gottlieb, T ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL ANTIGEN; CEFOTAXIME; CLARITHROMYCIN; GENTAMICIN; METRONIDAZOLE; PENICILLIN G; ROXITHROMYCIN;

AGED; ARTICLE; BACTERIUM CULTURE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EMERGENCY WARD; FEMALE; HUMAN; LABORATORY TEST; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL ANTIGEN TEST; POINT OF CARE TESTING; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; TURNOVER TIME; URINALYSIS;

AGED; ANTIGENS, BACTERIAL; COMMUNITY-ACQUIRED INFECTIONS; CROSS-SECTIONAL STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; PNEUMONIA, PNEUMOCOCCAL; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; STREPTOCOCCUS PNEUMONIAE;

EID: 40449107305     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2007.050179     Document Type: Article

References (27)

1. British Thoracic Society. Guidelines for the management of community acquired pneumonia in adults - 2001. Thorax 2001; 56(Suppl IV).
2. British Thoracic Society. Guidelines for the management of community acquired pneumonia in adults - 2004 update. http://www.brit-thoracic.org.uk/c2/uploads/MACAPrevisedApr04.pdf (accessed July 2007).
3. Anon. Respiratory tract infections: pneumonia. In: Therapeutic guidelines: antibiotic. Melbourne, Australia: Therapeutic Guidelines Ltd, 2006.
4. Musher DM, Alexandraki I, Graviss EA, et al. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 2000;79:210-21.
5. Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2004; 39:165-9.
6. Dominguez J, Gali N, Blanco S, et al. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest 2001;119:243-9.
7. Gutierrez F, Masia M, Rodriguez JC, et al. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin Infect Dis 2003;36:286-92.
8. Murdoch DR, Laing RT, Mills GD, et al. Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J Clin Microbiol 2001;39:3495-8.
9. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
10. Bonner A, Monroe K, Talley L, et al. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the paediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003; 112:363-7.
11. van der Eerden M, Vlaspolder F, de Graaff C, et al. Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community acquired pneumonia. Eur J Clin Microbiol Infect Dis 2005;24:241-9.
12. Murdoch DR, Laing RT, Cook JM. The NOW S pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD. Clin Infect Dis 2003;37:153-4.
13. Marcos MA, Martinez E, Almela M, et al. New rapid antigen test for diagnosis of pneumococcal meningitis. Lancet 2001; 357:1499-500.
14. Samra Z, Shmuely H, Nahum E, et al. Use of the NOW Streptococcus pneumoniae urinary antigen test in cerebrospinal fluid for rapid diagnosis of pneumococcal meningitis. Diagn Microbiol Infect Dis 2003;45:237-40.
15. Houck P, Bratzler D, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164:637-44.
16. Ewig S, Schlochtermeier M, Goke N, et al. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest 2002;121:1486-92.
17. Waterer GW, Jennings SG, Wunderink RG. The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia. Chest 1999;116:1278-81.
18. Martinez F. Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients. Clin Infect Dis 2004; 38(Suppl 4):S328-40.
19. Mills G, Oehley M, Arrol B. Effectiveness of beta-lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community-acquired pneumonia: meta-analysis. BMJ 2005;330:456-63.
20. Shefet D, Robenshtok E, Paul M, et al. Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 2005; 165:1992-2000.
21. Guchev I, Yu V, Sinopalnikov A, et al. Management of non-severe pneumonia in military trainees with the urinary antigen test for Streptococcus pneumonia: an innovative approach to targeted therapy. Clin Infect Dis 2005;40:1608-16.
22. Aspa J, Rajas O, Rodriguez de Castro F, et al. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin Infect Dis 2004;38:787-98.
23. Metlay JP, Hofmann J, Cetron MS, et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30:520-8.
24. Song J, Jung S, Ki H, et al. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian network for surveillance of resistant pathogens. Clin Infect Dis 2004;38:1570-8.
25. Yu V, Chiou C, Feldman C, et al. An international prospective study of pneumococcal bacteraemia: correlation with in-vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003;37:230-7.
26. Oosterheert JJ, Bonten MJ, Buskens E, et al. Algorithm to determine cost savings of targeting antimicrobial therapy based on results of rapid diagnostic testing. J Clin Microbiol 2003; 41:4708-13.
27. Commonwealth Department of Health and Ageing. National Notifiable Diseases Surveillance System. Volume 2006: Communicable Diseases Australia. Commonwealth Department of Health and Ageing, 2005.